Found: 36
Select item for more details and to access through your institution.
Shared and distinct mechanisms of UBA1 inactivation across different diseases.
- Published in:
- EMBO Journal, 2024, v. 43, n. 10, p. 1919, doi. 10.1038/s44318-024-00046-z
- By:
- Publication type:
- Article
Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. e50, doi. 10.1111/bjh.18961
- By:
- Publication type:
- Article
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots.
- Published in:
- Human Mutation, 2023, p. 1, doi. 10.1155/2023/4880113
- By:
- Publication type:
- Article
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2633, doi. 10.1007/s00277-022-04993-7
- By:
- Publication type:
- Article
PCR‐Fluo‐ASXL1‐FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignancies.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 5, p. 928, doi. 10.1111/ijlh.13931
- By:
- Publication type:
- Article
Acquired spherocytosis due to somatic ANK1 mutations as a manifestation of clonal hematopoiesis in elderly patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E285, doi. 10.1002/ajh.26593
- By:
- Publication type:
- Article
The Mesenchymal Niche in Myelodysplastic Syndromes.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/diagnostics12071639
- By:
- Publication type:
- Article
VEXAS Syndrome: A Novelty in MDS Landscape.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/diagnostics12071590
- By:
- Publication type:
- Article
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E159, doi. 10.1002/ajh.26479
- By:
- Publication type:
- Article
Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level.
- Published in:
- BMC Biology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12915-022-01264-9
- By:
- Publication type:
- Article
Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 969, doi. 10.1111/bjh.17893
- By:
- Publication type:
- Article
Atypical splice-site mutations causing VEXAS syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 286, doi. 10.1111/bjh.17679
- By:
- Publication type:
- Article
Severe Joint Involvement in VEXAS Syndrome: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- case study
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 588, doi. 10.1111/ejh.13492
- By:
- Publication type:
- Article
Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome.
- Published in:
- 2020
- By:
- Publication type:
- case study
Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia.
- Published in:
- Oncogenesis, 2020, v. 9, n. 10, p. 1, doi. 10.1038/s41389-020-00278-8
- By:
- Publication type:
- Article
Distinct mutational pattern of myelodysplastic syndromes with and without 5q– treated with lenalidomide.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. e133, doi. 10.1111/bjh.16558
- By:
- Publication type:
- Article
Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1‐tube panel strategy for diagnosis and prognosis of patients with MDS.
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 3, p. 226, doi. 10.1002/cyto.b.21843
- By:
- Publication type:
- Article
Stratégie d'accréditation des anomalies moléculaires somatiques rares détectées ou quantifiées par polymerase chain reaction : recommandations du GBMHM.
- Published in:
- Annales de Biologie Clinique, 2019, v. 77, n. 6, p. 681, doi. 10.1684/abc.2019.1498
- By:
- Publication type:
- Article
Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 1, p. 65, doi. 10.1111/bjh.16045
- By:
- Publication type:
- Article
The fraction of CD117/c‐KIT‐expressing erythroid precursors predicts ESA response in low‐risk myelodysplastic syndromes.
- Published in:
- Cytometry. Part B, 2019, v. 96, n. 3, p. 215, doi. 10.1002/cyto.b.21781
- By:
- Publication type:
- Article
Establishing assay-specific 97.5th percentile upper reference limit for serum D-2-hydroxyglutarate for the management of patients with acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 625, doi. 10.1111/bjh.15584
- By:
- Publication type:
- Article
Développement des analyses moléculaires par PCR digitale pour la pratique clinique : principes, mise en œuvre pratique et recommandations.
- Published in:
- Annales de Biologie Clinique, 2018, v. 76, n. 5, p. 505, doi. 10.1684/abc.2018.1372
- By:
- Publication type:
- Article
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- case study
Diversity of TP53 Mutations in CLL: Retrospective Analysis of 450 Mutations from the French Innovative Leukemia Organization (FILO) Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S301, doi. 10.1016/j.clml.2017.07.096
- By:
- Publication type:
- Article
Efficacy of 5-Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 6, p. 913, doi. 10.1111/bjh.13170
- By:
- Publication type:
- Article
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic- French Consortium Study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1111, doi. 10.1002/ajh.23846
- By:
- Publication type:
- Article
Sustained Leukemia-Free State and Molecular Response to Sorafenib in a Patient With Chronic Myelomonocytic Leukemia in Transformation Driven by Homozygous FLT3-ITD Malignant Hematopoiesis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 347, doi. 10.1016/j.clml.2012.11.007
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitors Induce Down-Regulation of c-Kit by Targeting the ATP Pocket.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060961
- By:
- Publication type:
- Article
Mutations des gènes impliqués dans l’épissage dans les hémopathies malignes humaines.
- Published in:
- Médecine Sciences, 2012, v. 28, n. 5, p. 449, doi. 10.1051/medsci/2012285002
- By:
- Publication type:
- Article
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 460, doi. 10.1111/j.1365-2141.2010.08393.x
- By:
- Publication type:
- Article
Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations.
- Published in:
- Genes, Chromosomes & Cancer, 2010, v. 49, n. 10, p. 919, doi. 10.1002/gcc.20802
- By:
- Publication type:
- Article
Erythropoietin Down-Regulates Stem Cell Factor Receptor (Kit) Expression in the Leukemic Proerythroblast: Role of Lyn Kinase.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005721
- By:
- Publication type:
- Article